IN BRIEF: PureTech's Akili In Green Light For Video Game ADHD Therapy
IN BRIEF: PureTech's Akili In Green Light For Video Game ADHD Therapy
Read moreTue, 18th Dec 2018 11:09
IN BRIEF: PureTech's Akili In Green Light For Video Game ADHD Therapy
Read more(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health announced on Tuesday that its subsidiary Akili has been granted US Food and Drug Administration (FDA) clearance for 'EndeavorRx', or AKL-T01, as a prescription treatment for children with attention deficit hyperactivity disorder (ADHD).
Read moreUK TRADING UPDATE SUMMARY: Venture Life Sees Order Boost For Sanitiser
Read more(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health reported some "positive" topline data from two Phase 1 studies into VE202, its orally-administered inflammatory bowel disease treatment candidate.
Read moreUK TRADING UPDATE SUMMARY: Open Orphan Launches Covid Testing Service
Read moreUK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million
Read more(Sharecast News) - Clinical stage biotherapeutics company PureTech Health announced on Tuesday that its founded company Gelesis has received approval to market 'Plenity', a novel weight-loss treatment, in Europe.
Read moreUK TRADING UPDATE SUMMARY: PureTech, N4, Synairgen Advance Covid Work
Read more(Sharecast News) - PureTech Health announced plans on Thursday to advance its wholly-owned clinical-stage product candidate 'LYT-100', or deupirfenidone, as a potential treatment for serious respiratory complications, including inflammation and fibrosis, that persist following the resolution of Covid-19 infection.
Read moreUK EXECUTIVE CHANGE SUMMARY: New Chairs For Matomy And Shield
Read more(Sharecast News) - Clinical stage biotechnology company PureTech Health said on Tuesday that it had received $45m from the sale of 555,500 shares of its founded entity Karuna Therapeutics.
Read moreUK DIRECTOR DEALINGS SUMMARY: Novacyt Chair And CEO Step In To Buy
Read morePureTech Health Swings To Annual Profit On Exceptional Gains
Read more(Sharecast News) - Clinical-stage biotherapeutics company Puretech Health posted weaker full-year revenues and a widened operating loss on Thursday and also noted it was yet to see any impact to ongoing work as a result of the Covid-19 outbreak.
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read more